Matches in Wikidata for { <http://www.wikidata.org/entity/Q90046770> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q90046770 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90046770 description "scientific article published on 01 April 2019" @default.
- Q90046770 description "wetenschappelijk artikel" @default.
- Q90046770 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q90046770 name "EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases" @default.
- Q90046770 name "EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases" @default.
- Q90046770 type Item @default.
- Q90046770 label "EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases" @default.
- Q90046770 label "EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases" @default.
- Q90046770 prefLabel "EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases" @default.
- Q90046770 prefLabel "EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases" @default.
- Q90046770 P1433 Q90046770-97713F49-C82B-4E60-BA9B-997B0C684B87 @default.
- Q90046770 P1476 Q90046770-E248EDE9-8B34-4524-9A43-AB6FC00DFBE8 @default.
- Q90046770 P2093 Q90046770-886475AE-6BD7-43A9-BE01-417BE7FFE966 @default.
- Q90046770 P2093 Q90046770-B9851FFC-0908-4137-8F62-98C1B9CE87DA @default.
- Q90046770 P304 Q90046770-4837E8D0-8CEC-45C0-86E7-F09B0A617A50 @default.
- Q90046770 P31 Q90046770-0D998CAB-28A9-4328-BEF9-22C32BAACFD1 @default.
- Q90046770 P356 Q90046770-A1D898A7-9E72-4604-A302-78AACC274A4C @default.
- Q90046770 P478 Q90046770-107FA008-3653-4163-90F2-F632B6578028 @default.
- Q90046770 P577 Q90046770-E5B1A6E7-5480-4CC7-98CA-D9F7B89F25E3 @default.
- Q90046770 P921 Q90046770-AA7476C5-B8EC-485E-A892-328FF89F1330 @default.
- Q90046770 P921 Q90046770-B715A74F-3EC3-4A92-B7E2-52592A56B410 @default.
- Q90046770 P921 Q90046770-D61F34B6-70EC-429A-9E40-D4EF24584CD8 @default.
- Q90046770 P356 MDZ068 @default.
- Q90046770 P1433 Q326122 @default.
- Q90046770 P1476 "EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases" @default.
- Q90046770 P2093 "C Zhou" @default.
- Q90046770 P2093 "T Jiang" @default.
- Q90046770 P304 "ii69-ii70" @default.
- Q90046770 P31 Q13442814 @default.
- Q90046770 P356 "10.1093/ANNONC/MDZ068" @default.
- Q90046770 P478 "30 Suppl 2" @default.
- Q90046770 P577 "2019-04-01T00:00:00Z" @default.
- Q90046770 P921 Q1620196 @default.
- Q90046770 P921 Q3658562 @default.
- Q90046770 P921 Q413299 @default.